Clinical and Commercial Depot Services for New Zealand
Australian regional depot services supporting clinical, early access and commercial medicine supply into New Zealand
HL Pharma operates a specialist clinical and commercial pharmaceutical depot in Melbourne, supporting pharmaceutical companies, biotechnology sponsors, manufacturers, CROs and distributors supplying medicines into New Zealand.
Our regional depot provides validated temperature-controlled storage, inventory management, clinical supply services, pharmaceutical logistics and export coordination. Importation and local distribution within New Zealand are undertaken through appropriately licensed New Zealand partners and remain subject to applicable regulatory, clinical and import requirements.
Clinical Trial and Early Access Supply
HL Pharma supports international sponsors and CROs managing clinical trials, early access programmes and continued medicine access in New Zealand.
Services may include temperature-controlled storage of investigational and specialist medicines, carton and unit-level inventory management, site replenishment, shipment preparation, returns, reconciliation and destruction of unused materials. We also support clinical trial extensions, rollover arrangements, Managed Access Programmes and continued treatment following trial completion, working alongside sponsors, research sites, regulatory advisers and licensed New Zealand supply partners.
For programmes requiring continued supply before or after a clinical trial, find out more about our Early & Post-Clinical Trial Supply & Access services.
Small-batch and early-phase clinical trial distribution
Our Melbourne depot supports small-batch, early-phase and limited-volume clinical trial supply for New Zealand without minimum volume requirements.
Services include carton and unit-level inventory management, named-patient shipment preparation, temperature-controlled storage, site replenishment and export coordination within a GDP-aligned quality system, providing sponsors with a practical regional clinical trial depot option for smaller, specialist or complex New Zealand programmes.
Commercial medicines supply support
For commercial and pre-commercial medicines, HL Pharma provides pharmaceutical storage, inventory control, quarantine management, order fulfilment and export supply support from our Melbourne depot.
Operations are supported by a validated Warehouse Management System and secure client portal providing 24/7 visibility of stock movements, batch details, expiry dates, quarantine status and inventory history. This enables sponsors and manufacturers to manage regional pharmaceutical inventory in Australia while New Zealand importation, release and local distribution are coordinated through appropriately licensed partners.
Temperature-controlled and secure storage
Our Melbourne facility provides validated controlled room temperature, refrigerated, frozen and ultra-low temperature storage for medicines destined for New Zealand and regional markets.
Secure, access-controlled areas are available for controlled drugs and other high-value or specialist medicines, subject to applicable Australian licences and permits. Validated temperature mapping, continuous monitoring, real-time alerts and documented escalation procedures support product integrity from receipt through to export dispatch.
Quality, licensing and oversight
HL Pharma operates within an ISO 9001:2015-certified quality management system, certified by BSI under Certificate FS819588. Our Australian facility processes are aligned with Good Distribution Practice principles and applicable Australian Good Wholesaling Practice requirements. Electronic records, audit trails and secure electronic signatures are aligned with 21 CFR Part 11 and EU Annex 11 expectations.
For companies supplying New Zealand, this provides an established regional pharmaceutical depot with documented quality controls, product traceability and experienced operational oversight. Learn more about our Quality, Regulatory & Compliance Framework
A Regional Depot Model for New Zealand
HL Pharma’s Melbourne facility provides sponsors, manufacturers and CROs with a regional inventory and supply point for New Zealand, particularly where local volumes are smaller, medicines are specialist or supply requirements extend across Australia and New Zealand.
Stock can be received, stored and managed within our Australian pharmaceutical quality system, with onward export supply coordinated into New Zealand through appropriately licensed local partners. This provides a practical trans-Tasman supply model for clinical, early access and commercial medicines.
Who We Support
HL Pharma supports pharmaceutical and biotechnology companies, clinical trial sponsors, CROs, manufacturers and distributors requiring regional depot services for clinical, early access and commercial medicine supply into New Zealand.